SYNOVUS FINANCIAL CORP - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 118 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$1,0002330.0%0.00%
Q1 2020$02330.0%0.00%
Q4 2019$0
-100.0%
2330.0%0.00%
Q3 2019$1,000
-50.0%
2330.0%0.00%
Q2 2019$2,000
-33.3%
2330.0%0.00%
Q1 2019$3,000
+50.0%
2330.0%0.00%
Q4 2018$2,000
-33.3%
2330.0%0.00%
Q3 2018$3,0002330.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders